Evidence map›Paper›PMID 33782464›Full record

ArticleScientific reports2021

The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs.

Khalid N M Abdelazeem, M Zaher Kalo, Sandra Beer-Hammer, Florian Lang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Distinct classes of gut bacterial molybdenum-dependent enzymes produce urolithins.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Khalid N M AbdelazeemDepartment of Internal Medicine III, Eberhard Karls University of Tübingen, Tübingen, Germany.
M Zaher KaloDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomic, University of Tübingen, Wilhelmstrasse 56, 72074, Tübingen, Germany.
Sandra Beer-HammerDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomic, University of Tübingen, Wilhelmstrasse 56, 72074, Tübingen, Germany. sandra.beer-hammer@uni-tuebingen.de.
Florian LangDepartment of Internal Medicine III, Eberhard Karls University of Tübingen, Tübingen, Germany.
University of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a natural defense process of the innate immune system, associated with the release of proinflammatory cytokines such as interleukin-1β, interleukin-6, interleukin-12 and TNFα; and enzymes including iNOS through the activation and nuclear translocation of NF-κB p65 due to the phosphorylation of IκBα. Regulation of intracellular Ca

Indexed as

Gastrointestinal MicrobiomeAnimalsCalciumCoumarinsDNA Breaks, Double-StrandedInflammationInflammation MediatorsLipopolysaccharidesMacrophagesMiceMicroRNAsNF-kappa BRAW 264.7 CellsReactive Oxygen SpeciesSignal TransductionToll-Like Receptor 43,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneCalciumCoumarinsInflammation MediatorsLipopolysaccharidesMicroRNAsNF-kappa BReactive Oxygen SpeciesTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID33782464
PMCPMC8007722
OpenAlexW3151624572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.